Alumis
Price & Volume
Stats
See more52W Range | $3.76-$31.35 |
Market Cap | $3.2B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $7.3M |
Revenue Growth (YoY) | -37.7% |
Gross Profit (12 Mos) | $7.3M |
Diluted EPS | -$4.11 |
News
See moreYahoo Finance • 6 days ago
High-flyer healthcare stocks: Ten names with strong momentum, weak valuations
Yahoo Finance • 3 months ago
What This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
Yahoo Finance • 3 months ago
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
Yahoo Finance • 4 months ago
Commit To Buy Alumis At $15, Earn 34.6% Annualized Using Options
About
CEO | Mr. Martin Babler Ph.D. |
Address | 280 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 237 |